Cargando…
Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widespread and persistent pollutants that have been associated with elevated cholesterol levels. However, data on incident cardiovascular disease (CVD) is lacking. OBJECTIVES: We investigated the association of exposure to PFAS with risk of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Environmental Health Perspectives
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919955/ https://www.ncbi.nlm.nih.gov/pubmed/35285690 http://dx.doi.org/10.1289/EHP9791 |
_version_ | 1784669028063641600 |
---|---|
author | Schillemans, Tessa Donat-Vargas, Carolina Lindh, Christian H. de Faire, Ulf Wolk, Alicja Leander, Karin Åkesson, Agneta |
author_facet | Schillemans, Tessa Donat-Vargas, Carolina Lindh, Christian H. de Faire, Ulf Wolk, Alicja Leander, Karin Åkesson, Agneta |
author_sort | Schillemans, Tessa |
collection | PubMed |
description | BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widespread and persistent pollutants that have been associated with elevated cholesterol levels. However, data on incident cardiovascular disease (CVD) is lacking. OBJECTIVES: We investigated the association of exposure to PFAS with risk of myocardial infarction and stroke and, subsidiary, with baseline blood lipids. METHODS: This population-based nested case–control study included first incident myocardial infarction and stroke cases with matched controls from two Swedish cohorts: the Swedish Mammography Cohort-Clinical (SMC-C) and the Cohort of 60-year-olds (60YO). Baseline blood sampling occurred during 2003–2009 and 1997–1999 with follow-up through 2017 and 2014 for the SMC-C and the 60YO, respectively. Eight plasma PFAS concentrations were measured using targeted liquid chromatography–triple quadrupole mass spectrometry. Five of these were quantifiable in both cohorts; individual values and their standardized sum were categorized into tertiles based on the controls. First incident myocardial infarction ([Formula: see text]) and ischemic stroke ([Formula: see text]) cases were ascertained via linkage to the National Inpatient Register and the Cause of Death Register. Controls were randomly selected from each cohort after matching for age, sex, and sample date. Baseline blood lipids were measured in plasma or serum after overnight fasting. RESULTS: Among the 1,528 case–control subjects, the mean (standard deviation) age was 66 (7.7) y and 67% of them were women. In multivariable-adjusted analyses, the third tertile of the standardized sum of five PFAS associated with higher cholesterol and lower triglyceride levels among controls at baseline ([Formula: see text]). The corresponding results were [Formula: see text] [95% confidence interval (CI): 0.53, 0.93] for CVD, 0.60 (95% CI: 0.39, 0.92) for myocardial infarction, and 0.83 (95% CI: 0.46, 1.50) for stroke. DISCUSSION: This study indicated that exposure to PFAS, although associated with increased cholesterol levels, did not associate with an increased risk of myocardial infarction, stroke, or their composite end point. The findings improve our knowledge on potential health effects of environmental contaminants in the CVD context. https://doi.org/10.1289/EHP9791 |
format | Online Article Text |
id | pubmed-8919955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Environmental Health Perspectives |
record_format | MEDLINE/PubMed |
spelling | pubmed-89199552022-03-17 Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden Schillemans, Tessa Donat-Vargas, Carolina Lindh, Christian H. de Faire, Ulf Wolk, Alicja Leander, Karin Åkesson, Agneta Environ Health Perspect Research BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widespread and persistent pollutants that have been associated with elevated cholesterol levels. However, data on incident cardiovascular disease (CVD) is lacking. OBJECTIVES: We investigated the association of exposure to PFAS with risk of myocardial infarction and stroke and, subsidiary, with baseline blood lipids. METHODS: This population-based nested case–control study included first incident myocardial infarction and stroke cases with matched controls from two Swedish cohorts: the Swedish Mammography Cohort-Clinical (SMC-C) and the Cohort of 60-year-olds (60YO). Baseline blood sampling occurred during 2003–2009 and 1997–1999 with follow-up through 2017 and 2014 for the SMC-C and the 60YO, respectively. Eight plasma PFAS concentrations were measured using targeted liquid chromatography–triple quadrupole mass spectrometry. Five of these were quantifiable in both cohorts; individual values and their standardized sum were categorized into tertiles based on the controls. First incident myocardial infarction ([Formula: see text]) and ischemic stroke ([Formula: see text]) cases were ascertained via linkage to the National Inpatient Register and the Cause of Death Register. Controls were randomly selected from each cohort after matching for age, sex, and sample date. Baseline blood lipids were measured in plasma or serum after overnight fasting. RESULTS: Among the 1,528 case–control subjects, the mean (standard deviation) age was 66 (7.7) y and 67% of them were women. In multivariable-adjusted analyses, the third tertile of the standardized sum of five PFAS associated with higher cholesterol and lower triglyceride levels among controls at baseline ([Formula: see text]). The corresponding results were [Formula: see text] [95% confidence interval (CI): 0.53, 0.93] for CVD, 0.60 (95% CI: 0.39, 0.92) for myocardial infarction, and 0.83 (95% CI: 0.46, 1.50) for stroke. DISCUSSION: This study indicated that exposure to PFAS, although associated with increased cholesterol levels, did not associate with an increased risk of myocardial infarction, stroke, or their composite end point. The findings improve our knowledge on potential health effects of environmental contaminants in the CVD context. https://doi.org/10.1289/EHP9791 Environmental Health Perspectives 2022-03-14 /pmc/articles/PMC8919955/ /pubmed/35285690 http://dx.doi.org/10.1289/EHP9791 Text en https://ehp.niehs.nih.gov/about-ehp/licenseEHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. |
spellingShingle | Research Schillemans, Tessa Donat-Vargas, Carolina Lindh, Christian H. de Faire, Ulf Wolk, Alicja Leander, Karin Åkesson, Agneta Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden |
title | Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden |
title_full | Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden |
title_fullStr | Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden |
title_full_unstemmed | Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden |
title_short | Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden |
title_sort | per- and polyfluoroalkyl substances and risk of myocardial infarction and stroke: a nested case–control study in sweden |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919955/ https://www.ncbi.nlm.nih.gov/pubmed/35285690 http://dx.doi.org/10.1289/EHP9791 |
work_keys_str_mv | AT schillemanstessa perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden AT donatvargascarolina perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden AT lindhchristianh perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden AT defaireulf perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden AT wolkalicja perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden AT leanderkarin perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden AT akessonagneta perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden |